APA

Panday V. R., Huizing M. T., van Warmerdam L. J., Dubbelman R. C., Mandjes I., Schellens J. H., Huinink W. W. & Beijnen J. H. (19981117). Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer. : Pharmacological research.

Chicago

Panday V R, Huizing M T, van Warmerdam L J, Dubbelman R C, Mandjes I, Schellens J H, Huinink W W and Beijnen J H. 19981117. Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer. : Pharmacological research.

Harvard

Panday V. R., Huizing M. T., van Warmerdam L. J., Dubbelman R. C., Mandjes I., Schellens J. H., Huinink W. W. and Beijnen J. H. (19981117). Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer. : Pharmacological research.

MLA

Panday V R, Huizing M T, van Warmerdam L J, Dubbelman R C, Mandjes I, Schellens J H, Huinink W W and Beijnen J H. Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer. : Pharmacological research. 19981117.